MOVERS OF FRIDAY 4 DECEMBER 2020
(LON: MCRO ) Stocks rose 9.10% to 436.2 pence when Amazon received a nod
Shares in the global software company rose since news broke that Amazon (NASDAQ: AMZN) had given the group a full vote of confidence in helping companies migrate to the cloud.
Micro Focus stock was up 17% as a result of the news announced Thursday at 3 p.m. EST, but was up 25% at the start of the session.
According to US publication Motley Fool, Amazon announced to investors that it had selected several companies to help companies relocate their businesses in the Amazon Web Services (AWS) blog post, citing Micro Focus as one of the four pre-qualified technology partners .
“While there is no indication of what this means for future Micro Focus revenues, it certainly won’t hurt.” Given the company saw a 10% year-over-year revenue decline in fiscal 2020, this could be a catalyst for a return to growth, “the publication wrote.
(GOAL: N4P ) Stocks rose 38.46% to 10.8p as positive results were reported
The pharmaceutical specialist focused on the development of Nuvec® reported positive results this morning as part of its ongoing research collaboration agreement with Nanomerics.
As reported in February 2020, the group initiated the first phase of research to test the stability of various formulations of Nuvec® loaded with well-characterized plasmid DNA.
N4 said that Nuvec® formulations that were freeze-dried and then stored for 14 days at either room temperature or four degrees Celsius showed “no significant decrease in in vitro transfection ability after reconstitution compared to fresh formulations”.
In parallel to the ongoing work on the analysis of the stability period, various formulations are now being selected in order to move on to the second phase of the work program, in which the effectiveness of the dried and reconstituted plasmid DNA is tested in an in vivo antibody generation model.
“The demonstration that Nuvec® loaded with a plasmid DNA can be dried, stored at appropriate temperatures and reconstituted without drops of transfection is a significant advance in our formulation development work,” said Nigel Theobald, CEO of N4 Pharma.
He said, “Work in this area will continue and expand the breadth of proof-of-concept data we are producing for the use of Nuvec® as a delivery system for vaccines and cancer treatments.”
(GOAL: HUNTING ) Shares rose 28.21% to 65p in a potential offering
The company announced this morning to investors that it is in talks of a purchase by bigger rival The Property Franchise Group as UK real estate agents look to consolidate.
In its morning statement, Hunters announced that TPFG had received a preliminary estimate of a potential offer, but did not disclose details of the potential offer price.
‘The approach is tentative and the terms continue to be discussed and carefully reviewed by Hunters and TPFG. Accordingly, there can be no certainty that an offer will be made, nor about the terms and conditions of an offer, if it is made, ”emphasized the company.
According to Sky News, the approach follows days after recent developments in yet another takeover battle within the real estate industry, with real estate group Countrywide being “the center of competing proposals” from Connells and Alchemy Partners, the private equity firm.
(GOAL: IPI Stocks rose 16.28% to 2.5p as they float for profit
The X-ray screening systems provider made a profit for the fiscal year ended September 30, 2020 after the group posted a pre-tax trading profit of £ 0.113 million (FY 19: loss of £ 0.402 million).
In the reporting period, IGE recorded a 50% increase in sales to GBP 3.5 million (FY 19: GBP 2.4 million) after a “strong first half of the year based on a large portable X-ray contract won at the end of last year” .
The company stressed that while 2H20 saw “lower levels of activity” as coronavirus slowed new business, the company continued to win contracts, operate its manufacturing facility and support its customers during the ongoing pandemic.
It added that careful management of costs and inventory had resulted in “strong cash generation”.
The group said it remains difficult to predict when security systems spending may return to more normal levels, but stressed its confidence that the expanded product line and broad market access puts the group in a good position to take advantage of.
(LON: CINE Shares fell 11.29% to 64.82 pence after the Warner Bros slap
The cinema chain’s stocks fell today after it was announced that Warner Bros will release all 2021 films in the US on the same day they hit theaters on the HBO Max streaming service.
“We live in unprecedented times where creative solutions are required, including this new initiative for Warner Bros. Pictures Group,” said Ann Sarnoff, CEO of Warner Bros.
She adds, “Nobody wants to bring more films back to the screen than we do. We know that new content is the lifeblood of the theater show, but we need to balance this with the reality that most theaters in the US are likely to operate at reduced capacity by 2021. ”
According to multiple reports, Cineworld could lose a huge chunk of the revenue that Warner Bros’ upcoming blockbusters, including Dune and The Matrix 4, would have made.
‘And it’s particularly bad news for this particular UK stock. It urgently needs to start attracting the punters to pay off its colossal mountain of debt, ”says The Motley Fool.
The cinema industry has had a year of turbulence. In 2019, people went to a movie theater an average of less than four times, according to Bloomberg – a record low since 2002.
Though stocks have risen over 20% since late November 2020 when Cineworld arranged additional $ 450 million banking facilities to keep them alive through May 2021, this latest news means the movie theater chain will be in 2021 and above is also exposed to further short-term uncertainties.